Onderzoeker
Lisa Moris
- Disciplines:Urologie en nefrologie niet elders geclassificeerd, Andrologie, Kankerbiologie
Affiliaties
- Departement Cellulaire en Moleculaire Geneeskunde (Departement)
Lid
Vanaf2 aug 2020 → 14 jun 2022 - Laboratorium voor Moleculaire Endocrinologie (Afdeling)
Lid
Vanaf1 aug 2016 → 31 jul 2020
Projecten
1 - 1 of 1
- Klinische en pre-klinische studies van modulatoren van hoog-risico prostaatkanker met metastatisch potentieelVanaf1 aug 2016 → 29 apr 2022Financiering: BOF - doctorale mandaten, Privé-financiering van binnenlandse oorsprong - onbepaald
Publicaties
31 - 40 van 53
- Prognostic score predicts overall survival following complete urinary tract extirpation(2020)
Auteurs: Murat Akand, Tim Muilwijk, Frank Van der Aa, Thomas Gevaert, Lisa Moris, Hendrik Van Poppel, Maarten Albersen, Steven Joniau
Pagina's: 70 - 79 - EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)(2019)
Auteurs: Lisa Moris, Hendrik Van Poppel
Pagina's: 790 - 813 - Drivers of AR indifferent anti-androgen resistance in prostate cancer cells(2019)
Auteurs: Florian Handle, Stefan Prekovic, Christine Helsen, Thomas Van den Broeck, Elien Smeets, Lisa Moris, Roy Eerlings, Sarah El Kharraz, Steven Joniau, Frank Claessens
- Comparison of Peri-operative and Early Oncological Outcomes of Robot-Assisted vs. Open Salvage Lymph Node Dissection in Recurrent Prostate Cancer(2019)
Auteurs: Gaëtan Devos, Tim Muilwijk, Lisa Moris, Charlien Berghen, Gert De Meerleer, Maarten Albersen, Wouter Everaerts, Steven Joniau
- Impact of neoadjuvant chemotherapy on short-term complications and survival following radical cystectomy(2019)
Auteurs: Uros Milenkovic, Murat Akand, Lisa Moris, Tim Muilwijk, Youri Bekhuis, Annouschka Laenen, Ben Van Cleynenbreugel, Wouter Everaerts, Hendrik Van Poppel, Herlinde Dumez, et al.
Pagina's: 1857 - 1866 - Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery(2019)
Auteurs: Lisa Moris, Thomas Gevaert, Elien Smeets, Christine Helsen, Hendrik Van Poppel, Wouter Everaerts, Frank Claessens, Steven Joniau
Pagina's: 589 - 596 - Metastasectomy for visceral and skeletal oligorecurrent prostate cancer(2019)
Auteurs: Gaëtan Devos, Lisa Moris, Charlien Berghen, Wouter Everaerts, Maarten Albersen, Gert De Meerleer, Hendrik Van Poppel, Karolien Goffin, Steven Joniau
Pagina's: 1543 - 1549 - Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review(2019)
Auteurs: Thomas Van den Broeck, Lisa Moris
Pagina's: 967 - 987 - Study Protocol for the DETECTIVE Study: An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer(2019)
Auteurs: Thomas Van den Broeck, Lisa Moris, Hendrik Van Poppel
Pagina's: 699 - 702 - IMPACT OF CLINICAL TUMOR STAGE AND PREOPERATIVE PSA-VALUE ON CANCER SPECIFIC SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WITH GLEASON 9-10 ON PROSTATE BIOPSY(2019)
Auteurs: Gaëtan Devos, Alberto Briganti, Jeffrey Karnes, Bertrand Tombal, Henk Van der Poel, Jochen Walz, Alberto Bossi, Gert De Meerleer, Hein Van Poppel, Giansilvio Marchioro, et al.
Pagina's: E830 - E830